Skip to main content

11.02.2020 | Clinical Case Report

Multimodal imaging in a family with Cockayne syndrome with a novel pathogenic mutation in the ERCC8 gene, and significant phenotypic variability

verfasst von: Soungmin Cho, Elias I. Traboulsi, John Chiang, David Sierpina

Erschienen in: Documenta Ophthalmologica | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Cockayne syndrome is a rare autosomal recessive neurodegenerative disorder caused by mutations of either the ERCC6/CSB or ERCC8/CSA genes. Here, we describe two sisters with Cockayne syndrome caused by compound heterozygous mutations in the ERCC8 gene using multimodal imaging. Significant ophthalmic and systemic phenotypic variability is discussed.

Materials and methods

Multimodal imaging was performed in two affected sisters and included electroretinography, optical coherence tomography, ultra-wide-field confocal scanning laser ophthalmoscopy, fundus autofluorescence and fluorescein angiography, and magnetic resonance imaging. Genetic analyses were performed on the affected sisters, both parents, and three unaffected siblings.

Results

The older sister (Patient 1) had mental retardation, bilateral hearing loss, ataxia, and decreased visual acuity with retinal dystrophy. Radiographic studies revealed microcephaly, cerebral and cerebellar atrophy, ventriculomegaly, and a diffusely thickened skull. Full-field electroretinography waveforms were severely diminished with attenuation of cone and rod responses. The younger sister (Patient 2) had similar clinical features, including ataxia, bilateral hearing loss, and decreased visual acuity with retinal dystrophy. She also had paranoid schizophrenia. Wide-field fundus autofluorescence showed scattered areas of retinal pigment epithelium atrophy, which was different from her sister. Genetic analysis revealed two mutations in the ERCC8 gene shared by the sisters. These include an unreported missense point mutation: p.Thr328Ser:c.983C > G, and another previously reported pathogenic missense mutation: p.Ala205Pro:c.613G > C. Familial testing showed in trans segregation of these mutations with unaffected siblings inheriting one or neither mutation, but not both.

Conclusion

The clinical presentation and genetic studies confirmed a diagnosis of Cockayne syndrome in both sisters caused by compound heterozygous mutations in the ERCC8 gene on chromosome 10. Multimodal ocular imaging and systemic findings revealed wide phenotypic variability between the affected siblings.
Literatur
1.
Zurück zum Zitat Cleaver J, Lam E, Revet I (2009) Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat Rev Genet 10:756–768CrossRef Cleaver J, Lam E, Revet I (2009) Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat Rev Genet 10:756–768CrossRef
2.
Zurück zum Zitat Traboulsi E, De Becker I, Maumenee I (1992) Ocular findings in Cockayne syndrome. Am J Ophthalmol 114:579–583CrossRef Traboulsi E, De Becker I, Maumenee I (1992) Ocular findings in Cockayne syndrome. Am J Ophthalmol 114:579–583CrossRef
3.
Zurück zum Zitat Nance M, Berry A (1993) Cockayne syndrome: review of 140 cases. Am J Med Genet 42:68–84CrossRef Nance M, Berry A (1993) Cockayne syndrome: review of 140 cases. Am J Med Genet 42:68–84CrossRef
4.
Zurück zum Zitat Kubota M, Ohta S, Ando A et al (2015) Nationwide survey of Cockayne syndrome in Japan: incidence, clinical course and prognosis. Pediatr Int 57(3):339–347CrossRef Kubota M, Ohta S, Ando A et al (2015) Nationwide survey of Cockayne syndrome in Japan: incidence, clinical course and prognosis. Pediatr Int 57(3):339–347CrossRef
5.
Zurück zum Zitat Laugel V (2013) Cockayne syndrome: the expanding clinical and mutational spectrum. Mech Ageing Dev 134(5–6):161–170CrossRef Laugel V (2013) Cockayne syndrome: the expanding clinical and mutational spectrum. Mech Ageing Dev 134(5–6):161–170CrossRef
6.
Zurück zum Zitat Fousteri M, Vermeulen W, Zeeland A et al (2006) Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol Cell 23(4):461–482CrossRef Fousteri M, Vermeulen W, Zeeland A et al (2006) Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol Cell 23(4):461–482CrossRef
7.
Zurück zum Zitat Marteijn J, Lans H, Vermeulen W et al (2014) Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol 15(7):465–481CrossRef Marteijn J, Lans H, Vermeulen W et al (2014) Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol 15(7):465–481CrossRef
8.
Zurück zum Zitat Cao H, Williams C, Carter M et al (2004) CKN1 (MIM 216400): mutations in Cockayne syndrome type A and a new common polymorphism. J Hum Genet 49:61–63CrossRef Cao H, Williams C, Carter M et al (2004) CKN1 (MIM 216400): mutations in Cockayne syndrome type A and a new common polymorphism. J Hum Genet 49:61–63CrossRef
9.
Zurück zum Zitat Henning K, Li L, Iyer N et al (1995) The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell 82(4):555–564CrossRef Henning K, Li L, Iyer N et al (1995) The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell 82(4):555–564CrossRef
10.
Zurück zum Zitat Ridley A, Colley J, Wynford-Thomas D et al (2005) Characterisation of novel mutations in Cockayne syndrome type A and xeroderma pigmentosum group C subjects. J Hum Genet 50(3):151–154CrossRef Ridley A, Colley J, Wynford-Thomas D et al (2005) Characterisation of novel mutations in Cockayne syndrome type A and xeroderma pigmentosum group C subjects. J Hum Genet 50(3):151–154CrossRef
11.
Zurück zum Zitat Karikkineth A, Scheibye-Knudsen M, Fivenson E et al (2017) Cockayne syndrome: clinical features, model systems and pathways. Ageing Res Rev 33:3–17CrossRef Karikkineth A, Scheibye-Knudsen M, Fivenson E et al (2017) Cockayne syndrome: clinical features, model systems and pathways. Ageing Res Rev 33:3–17CrossRef
12.
Zurück zum Zitat Levin PS, Green WR, Victor DI, MacLean AL (1983) Histopathology of the eye in Cockayne’s syndrome. Arch Ophthalmol 101:1093–1097CrossRef Levin PS, Green WR, Victor DI, MacLean AL (1983) Histopathology of the eye in Cockayne’s syndrome. Arch Ophthalmol 101:1093–1097CrossRef
13.
Zurück zum Zitat Trese MG, Nudleman ED, Besirli CG (2017) Peripheral retinal vasculopathy in Cockayne syndrome. Retina Cases Brief Rep 11(3):232–235CrossRef Trese MG, Nudleman ED, Besirli CG (2017) Peripheral retinal vasculopathy in Cockayne syndrome. Retina Cases Brief Rep 11(3):232–235CrossRef
14.
Zurück zum Zitat Wu Y, Zheng Y, Yan X et al (2017) Ocular findings in a patient with Cockayne syndrome with two mutations in the ERCC gene. Ophthalmic Genet 38(2):175–177CrossRef Wu Y, Zheng Y, Yan X et al (2017) Ocular findings in a patient with Cockayne syndrome with two mutations in the ERCC gene. Ophthalmic Genet 38(2):175–177CrossRef
15.
Zurück zum Zitat Figueras-Roca M, Budi V, Morato M et al (2019) Cockayne syndrome in adults: complete retinal dysfunction exploration of two case reports. Doc Ophthalmol 138:241–246CrossRef Figueras-Roca M, Budi V, Morato M et al (2019) Cockayne syndrome in adults: complete retinal dysfunction exploration of two case reports. Doc Ophthalmol 138:241–246CrossRef
Metadaten
Titel
Multimodal imaging in a family with Cockayne syndrome with a novel pathogenic mutation in the ERCC8 gene, and significant phenotypic variability
verfasst von
Soungmin Cho
Elias I. Traboulsi
John Chiang
David Sierpina
Publikationsdatum
11.02.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 1/2020
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-020-09754-3

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.